US equities |
MU $887.60 ▼-2.90% NVDA $216.24 ▼-2.29% SNDK $1,314.43 ▼-6.34% SPCX $145.16 ▼-4.60% AMD $537.31 ▼-5.87% INTC $91.82 ▼-6.42% TSM $412.75 ▼-4.01% AAPL $344.94 ▲+0.58%
FinancialContent

Teleflex Incorporated Common Stock (NY:TFX)

124.83 +1.54 (+1.25%)
Delayed Quote Updated: 10:31 AM EDT, Oct 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teleflex Incorporated Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
Glancy Prongay & Murray LLP Announces Investigation of Teleflex Incorporated (TFX)
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
P/E Ratio Insights for Teleflex ↗
 
Via Benzinga
News headline image
Where Teleflex Stands With Analysts ↗
 
Via Benzinga
News headline image
Teleflex to Present at the 36th Annual Piper Sandler Healthcare Conference
From Teleflex Incorporated
Via GlobeNewswire
News headline image
Teleflex to Present at the Jefferies London Healthcare Conference
From Teleflex Incorporated
Via GlobeNewswire
News headline image
A Look Ahead: Teleflex's Earnings Forecast ↗
 
Via Benzinga
News headline image
Peering Into Teleflex's Recent Short Interest ↗
 
Via Benzinga
News headline image
Where Teleflex Stands With Analysts ↗
 
Via Benzinga
News headline image
Teleflex Announces Quarterly Dividend
From Teleflex Incorporated
Via GlobeNewswire
News headline image
Teleflex Reports Third Quarter Financial Results and Full Year 2024 Outlook
From Teleflex Incorporated
Via GlobeNewswire
News headline image
First Patient Enrolled in Teleflex’s Barrigel™ Rectal Spacer Trial for Post Radical Prostatectomy Radiation Therapy (PPRT)
Randomized, controlled study will be first in personalized spacing evidence to include patients who have a prostate cancer recurrence after prostatectomy. 
From Teleflex Incorporated
Via GlobeNewswire
News headline image
(TFX) - Analyzing Teleflex's Short Interest ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Teleflex? ↗
 
Via Benzinga
News headline image
Beyond The Numbers: 5 Analysts Discuss Teleflex Stock ↗
 
Via Benzinga
News headline image
A Glimpse Into The Expert Outlook On Teleflex Through 4 Analysts ↗
 
Via Benzinga
News headline image
New Data Presented at ASTRO 2024 Further Demonstrate the Safety and Efficacy of Barrigel™ Rectal Spacer, the First and Only Sculptable Hyaluronic Acid Rectal Spacer, in Patients Undergoing Radiation Therapy for Prostate Cancer(1-3)
From Teleflex Incorporated
Via GlobeNewswire
News headline image
Teleflex Announces Third Quarter 2024 Earnings Conference Call Information
From Teleflex Incorporated
Via GlobeNewswire
News headline image
Teleflex’s Barrigel Rectal Spacer to Be Featured in Three Presentations at the 2024 American Society for Radiation Oncology (ASTRO) Annual Meeting
From Teleflex Incorporated
Via GlobeNewswire
News headline image
(TFX) - Analyzing Teleflex's Short Interest ↗
 
Via Benzinga
News headline image
Peering Into Teleflex's Recent Short Interest ↗
 
Via Benzinga
News headline image
Teleflex™ Chooses o9’s AI-Powered Platform for End-to-End Integrated Business Planning and Supply Chain Management
From o9
Via Business Wire
News headline image
Teleflex to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
From Teleflex Incorporated
Via GlobeNewswire
News headline image
Teleflex Announces Publication of a Propensity Matching Review of Retrospective Data Reporting that the Titan SGS™ Stapler Enables Consistent Gastric Pouch Formation with Fewer Variations, Providing Potentially Enhanced Clinical Outcomes and Significant
From Teleflex Incorporated
Via GlobeNewswire
News headline image
Teleflex Announces Quarterly Dividend
From Teleflex Incorporated
Via GlobeNewswire
News headline image
Teleflex Reports Second Quarter Financial Results and Full Year 2024 Outlook
Announces $500 million share repurchase authorization inclusive of a $200 million accelerated share repurchase of common stock 
From Teleflex Incorporated
Via GlobeNewswire
News headline image
Teleflex Expands Interventional Cardiology Portfolio with FDA 510(k) Clearance of the Ringer™ Perfusion Balloon Catheter
This milestone highlights Teleflex’s commitment to providing interventionalists with new tools specifically engineered to address unmet clinical needs. 
From Teleflex Incorporated
Via GlobeNewswire
News headline image
Teleflex Awarded Hemostasis Products Agreements with Premier, Inc.
Hemostatic Dressings and Devices are Now Available at Special Pricing for Premier Members 
From Teleflex Incorporated
Via GlobeNewswire
News headline image
Teleflex Announces the Teleflex Center for Antimicrobial Protection
From Teleflex Incorporated
Via GlobeNewswire
News headline image
Teleflex Announces Second Quarter 2024 Earnings Conference Call Information
From Teleflex Incorporated
Via GlobeNewswire
News headline image
This Medical Devices Stock Has Several Catalysts, Says Bullish Analyst ↗
Teleflex gets an upgraded rating. Analyst Matt O'Brien takes it from Neutral to Overweight, and raises the price target from $205 to $245. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >